Executive summary of the 11th HHT international scientific conference

Helen Arthur, Urban Geisthoff, James R Gossage, Christopher C.W. Hughes, Pascal Lacombe, Mary E. Meek, Paul Oh, Beth L. Roman, Scott O. Trerotola, Sebastiaan Velthuis, Whitney Wooderchak-Donahue

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is a hereditary condition that results in vascular malformations throughout the body, which have a proclivity to rupture and bleed. HHT has a worldwide incidence of about 1:5000 and approximately 80 % of cases are due to mutations in ENG, ALK1 (aka activin receptor-like kinase 1 or ACVRL1) and SMAD4. Over 200 international clinicians and scientists met at Captiva Island, Florida from June 11–June 14, 2015 to present and discuss the latest research on HHT. 156 abstracts were accepted to the meeting and 60 were selected for oral presentations. The first two sections of this article present summaries of the basic science and clinical talks. Here we have summarized talks covering key themes, focusing on areas of agreement, disagreement, and unanswered questions. The final four sections summarize discussions in the Workshops, which were theme-based topical discussions led by two moderators. We hope this overview will educate as well as inspire those within the field and from outside, who have an interest in the science and treatment of HHT.

Original languageEnglish (US)
Pages (from-to)511-524
Number of pages14
JournalAngiogenesis
Volume18
Issue number4
DOIs
StatePublished - Oct 1 2015

Fingerprint

Activin Receptors
Hereditary Hemorrhagic Telangiectasia
Moderators
Vascular Malformations
Islands
Rupture
Education
Mutation
Incidence
Research

Keywords

  • ALK1
  • Arteriovenous malformation
  • Endoglin
  • Epistaxis
  • HHT
  • Hereditary hemorrhagic telangiectasia

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cancer Research

Cite this

Arthur, H., Geisthoff, U., Gossage, J. R., Hughes, C. C. W., Lacombe, P., Meek, M. E., ... Wooderchak-Donahue, W. (2015). Executive summary of the 11th HHT international scientific conference. Angiogenesis, 18(4), 511-524. https://doi.org/10.1007/s10456-015-9482-5

Executive summary of the 11th HHT international scientific conference. / Arthur, Helen; Geisthoff, Urban; Gossage, James R; Hughes, Christopher C.W.; Lacombe, Pascal; Meek, Mary E.; Oh, Paul; Roman, Beth L.; Trerotola, Scott O.; Velthuis, Sebastiaan; Wooderchak-Donahue, Whitney.

In: Angiogenesis, Vol. 18, No. 4, 01.10.2015, p. 511-524.

Research output: Contribution to journalArticle

Arthur, H, Geisthoff, U, Gossage, JR, Hughes, CCW, Lacombe, P, Meek, ME, Oh, P, Roman, BL, Trerotola, SO, Velthuis, S & Wooderchak-Donahue, W 2015, 'Executive summary of the 11th HHT international scientific conference', Angiogenesis, vol. 18, no. 4, pp. 511-524. https://doi.org/10.1007/s10456-015-9482-5
Arthur H, Geisthoff U, Gossage JR, Hughes CCW, Lacombe P, Meek ME et al. Executive summary of the 11th HHT international scientific conference. Angiogenesis. 2015 Oct 1;18(4):511-524. https://doi.org/10.1007/s10456-015-9482-5
Arthur, Helen ; Geisthoff, Urban ; Gossage, James R ; Hughes, Christopher C.W. ; Lacombe, Pascal ; Meek, Mary E. ; Oh, Paul ; Roman, Beth L. ; Trerotola, Scott O. ; Velthuis, Sebastiaan ; Wooderchak-Donahue, Whitney. / Executive summary of the 11th HHT international scientific conference. In: Angiogenesis. 2015 ; Vol. 18, No. 4. pp. 511-524.
@article{f00e57ee86244b3bb2c60b7bf04922d1,
title = "Executive summary of the 11th HHT international scientific conference",
abstract = "Hereditary hemorrhagic telangiectasia (HHT) is a hereditary condition that results in vascular malformations throughout the body, which have a proclivity to rupture and bleed. HHT has a worldwide incidence of about 1:5000 and approximately 80 {\%} of cases are due to mutations in ENG, ALK1 (aka activin receptor-like kinase 1 or ACVRL1) and SMAD4. Over 200 international clinicians and scientists met at Captiva Island, Florida from June 11–June 14, 2015 to present and discuss the latest research on HHT. 156 abstracts were accepted to the meeting and 60 were selected for oral presentations. The first two sections of this article present summaries of the basic science and clinical talks. Here we have summarized talks covering key themes, focusing on areas of agreement, disagreement, and unanswered questions. The final four sections summarize discussions in the Workshops, which were theme-based topical discussions led by two moderators. We hope this overview will educate as well as inspire those within the field and from outside, who have an interest in the science and treatment of HHT.",
keywords = "ALK1, Arteriovenous malformation, Endoglin, Epistaxis, HHT, Hereditary hemorrhagic telangiectasia",
author = "Helen Arthur and Urban Geisthoff and Gossage, {James R} and Hughes, {Christopher C.W.} and Pascal Lacombe and Meek, {Mary E.} and Paul Oh and Roman, {Beth L.} and Trerotola, {Scott O.} and Sebastiaan Velthuis and Whitney Wooderchak-Donahue",
year = "2015",
month = "10",
day = "1",
doi = "10.1007/s10456-015-9482-5",
language = "English (US)",
volume = "18",
pages = "511--524",
journal = "Angiogenesis",
issn = "0969-6970",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Executive summary of the 11th HHT international scientific conference

AU - Arthur, Helen

AU - Geisthoff, Urban

AU - Gossage, James R

AU - Hughes, Christopher C.W.

AU - Lacombe, Pascal

AU - Meek, Mary E.

AU - Oh, Paul

AU - Roman, Beth L.

AU - Trerotola, Scott O.

AU - Velthuis, Sebastiaan

AU - Wooderchak-Donahue, Whitney

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Hereditary hemorrhagic telangiectasia (HHT) is a hereditary condition that results in vascular malformations throughout the body, which have a proclivity to rupture and bleed. HHT has a worldwide incidence of about 1:5000 and approximately 80 % of cases are due to mutations in ENG, ALK1 (aka activin receptor-like kinase 1 or ACVRL1) and SMAD4. Over 200 international clinicians and scientists met at Captiva Island, Florida from June 11–June 14, 2015 to present and discuss the latest research on HHT. 156 abstracts were accepted to the meeting and 60 were selected for oral presentations. The first two sections of this article present summaries of the basic science and clinical talks. Here we have summarized talks covering key themes, focusing on areas of agreement, disagreement, and unanswered questions. The final four sections summarize discussions in the Workshops, which were theme-based topical discussions led by two moderators. We hope this overview will educate as well as inspire those within the field and from outside, who have an interest in the science and treatment of HHT.

AB - Hereditary hemorrhagic telangiectasia (HHT) is a hereditary condition that results in vascular malformations throughout the body, which have a proclivity to rupture and bleed. HHT has a worldwide incidence of about 1:5000 and approximately 80 % of cases are due to mutations in ENG, ALK1 (aka activin receptor-like kinase 1 or ACVRL1) and SMAD4. Over 200 international clinicians and scientists met at Captiva Island, Florida from June 11–June 14, 2015 to present and discuss the latest research on HHT. 156 abstracts were accepted to the meeting and 60 were selected for oral presentations. The first two sections of this article present summaries of the basic science and clinical talks. Here we have summarized talks covering key themes, focusing on areas of agreement, disagreement, and unanswered questions. The final four sections summarize discussions in the Workshops, which were theme-based topical discussions led by two moderators. We hope this overview will educate as well as inspire those within the field and from outside, who have an interest in the science and treatment of HHT.

KW - ALK1

KW - Arteriovenous malformation

KW - Endoglin

KW - Epistaxis

KW - HHT

KW - Hereditary hemorrhagic telangiectasia

UR - http://www.scopus.com/inward/record.url?scp=84943593815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943593815&partnerID=8YFLogxK

U2 - 10.1007/s10456-015-9482-5

DO - 10.1007/s10456-015-9482-5

M3 - Article

C2 - 26391603

AN - SCOPUS:84943593815

VL - 18

SP - 511

EP - 524

JO - Angiogenesis

JF - Angiogenesis

SN - 0969-6970

IS - 4

ER -